Comparison of Enoxaparin and Warfarin for the Prevention of Venous Thromboembolic Disease After Total Hip Arthroplasty. Evaluation During Hospitalization and Three Months After Discharge*
- 1 July 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Bone and Joint Surgery
- Vol. 81 (7), 932-40
- https://doi.org/10.2106/00004623-199907000-00005
Abstract
BackgroundVenous thromboembolic disease in the form of deep venous thrombosis and pulmonary embolism is a major risk after a total hip arthroplasty. Enoxaparin, a low-molecular-weight heparin, has been shown to reduce the prevalence of deep venous thrombosis after total hip arthroplasty. WarThis publication has 27 references indexed in Scilit:
- Comparison of the cost of preventing postoperative deep vein thrombosis with either unfractionated or low molecular weight heparinBritish Journal of Surgery, 1996
- Low-Molecular-Weight Heparin (Enoxaparin) as Prophylaxis against Venous Thromboembolism after Total Hip ReplacementNew England Journal of Medicine, 1996
- Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated HeparinNew England Journal of Medicine, 1995
- Prevention of postoperative venous thromboembolism: An updateThe American Journal of Surgery, 1994
- Effect of Laboratory Variation in the Prothrombin-Time Ratio on the Results of Oral Anticoagulant TherapyNew England Journal of Medicine, 1993
- Heparin-associated Thrombocytopenia: A Critical Review and Pooled AnalysisThe Lancet Healthy Longevity, 1993
- Heparin-induced thrombocytopenia and arterialthrombosis: Alternative therapiesAmerican Heart Journal, 1990
- A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip SurgeryNew England Journal of Medicine, 1986
- Progress in Preventing Venous ThromboembolismNew England Journal of Medicine, 1983
- Femoral vein thrombosis and total hip replacement.BMJ, 1977